Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Pharmaceutical Statistics
|
June 15, 2023
Alone, together: On the benefits of Bayesian borrowing in a meta-analytic setting
Ofir Harari, Mohsen Soltanifar, Andre Verhoek, et al.
Leukemia & Lymphoma
|
April 2, 2021
Involved free light chain: an early independent predictor of response and progression in multiple myeloma
Charlotte Gran, Gabriel Afram, Johan Liwing, et al.
Journal of Comparative Effectiveness Research
|
December 9, 2025
Simplifying fractional polynomials in Bayesian network meta-analysis via variable powers
Andre Verhoek, Mario Jnm Ouwens, Bart Heeg, et al.
Research Synthesis Methods
|
October 25, 2022
Network meta-interpolation: Effect modification adjustment in network meta-analysis using subgroup analyses
Ofir Harari, Mohsen Soltanifar, Joseph C Cappelleri, et al.
American Journal of Hematology
|
September 16, 2020
Comparative evaluation of involved free light chain and monoclonal spike as markers for progression from monoclonal gammopathy of undetermined significance to multiple myeloma
Charlotte Gran, Johan Liwing, Arnika Kathleen Wagner, et al.
Journal of Comparative Effectiveness Research
|
January 18, 2023
Bayesian hierarchical model-based network meta-analysis to overcome survival extrapolation challenges caused by data immaturity
Bart Heeg, Andre Verhoek, Gabriel Tremblay, et al.
Advances in Therapy
|
October 8, 2025
Matching-Adjusted Indirect Treatment Comparison of Tarlatamab Versus Comparator Therapies in England in Patients with Extensive-Stage Small Cell Lung Cancer Who Have Received Two or More Prior Lines of Therapy
Rumbidzai Takundwa, Gaurav Suri, Franziska Dirnberger, et al.
Hematology (Amsterdam, Netherlands)
|
January 6, 2023
Assessing the prognostic utility of hematologic response for overall survival in patients with newly diagnosed AL amyloidosis: results of a meta-analysis
Efstathios Kastritis, Arpit Misra, Laura Gurskyte, et al.
Journal of Comparative Effectiveness Research
|
September 12, 2022
Novel and existing flexible survival methods for network meta-analyses
Bart Heeg, Andrea Garcia, Sophie van Beekhuizen, et al.
Pharmacoeconomics - Open
|
February 22, 2023
Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer
Andre Verhoek, Parneet Cheema, Barbara Melosky, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Pharmaceutical Statistics
|
June 15, 2023
Alone, together: On the benefits of Bayesian borrowing in a meta-analytic setting
Ofir Harari, Mohsen Soltanifar, Andre Verhoek, et al.
Leukemia & Lymphoma
|
April 2, 2021
Involved free light chain: an early independent predictor of response and progression in multiple myeloma
Charlotte Gran, Gabriel Afram, Johan Liwing, et al.
Journal of Comparative Effectiveness Research
|
December 9, 2025
Simplifying fractional polynomials in Bayesian network meta-analysis via variable powers
Andre Verhoek, Mario Jnm Ouwens, Bart Heeg, et al.
Research Synthesis Methods
|
October 25, 2022
Network meta-interpolation: Effect modification adjustment in network meta-analysis using subgroup analyses
Ofir Harari, Mohsen Soltanifar, Joseph C Cappelleri, et al.
American Journal of Hematology
|
September 16, 2020
Comparative evaluation of involved free light chain and monoclonal spike as markers for progression from monoclonal gammopathy of undetermined significance to multiple myeloma
Charlotte Gran, Johan Liwing, Arnika Kathleen Wagner, et al.
Journal of Comparative Effectiveness Research
|
January 18, 2023
Bayesian hierarchical model-based network meta-analysis to overcome survival extrapolation challenges caused by data immaturity
Bart Heeg, Andre Verhoek, Gabriel Tremblay, et al.
Advances in Therapy
|
October 8, 2025
Matching-Adjusted Indirect Treatment Comparison of Tarlatamab Versus Comparator Therapies in England in Patients with Extensive-Stage Small Cell Lung Cancer Who Have Received Two or More Prior Lines of Therapy
Rumbidzai Takundwa, Gaurav Suri, Franziska Dirnberger, et al.
Hematology (Amsterdam, Netherlands)
|
January 6, 2023
Assessing the prognostic utility of hematologic response for overall survival in patients with newly diagnosed AL amyloidosis: results of a meta-analysis
Efstathios Kastritis, Arpit Misra, Laura Gurskyte, et al.
Journal of Comparative Effectiveness Research
|
September 12, 2022
Novel and existing flexible survival methods for network meta-analyses
Bart Heeg, Andrea Garcia, Sophie van Beekhuizen, et al.
Pharmacoeconomics - Open
|
February 22, 2023
Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer
Andre Verhoek, Parneet Cheema, Barbara Melosky, et al.
Page
of 1